camostat has been researched along with Diabetic Glomerulosclerosis in 3 studies
camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Camostat mesilate is a developed derivative of gabexate mesilate for oral administration and is known to be one of the most potent protease inhibitors." | 1.28 | Effect of camostat mesilate for the treatment of advanced diabetic nephropathy. ( Hotta, O; Ishizaki, M; Kurosawa, K; Matsubara, M; Suzuki, K; Taguma, Y, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, T | 1 |
| Hoshino, T | 1 |
| Matsubara, M | 2 |
| Taguma, Y | 2 |
| Saito, T | 1 |
| Yoshinaga, K | 1 |
| Kurosawa, K | 1 |
| Hotta, O | 1 |
| Suzuki, K | 1 |
| Ishizaki, M | 1 |
1 trial available for camostat and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Blood Coagulation; Captopril; | 1992 |
2 other studies available for camostat and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
An inhibition of urinary albumin excretion by protease inhibitor in streptozotocin-diabetic rats.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephr | 1996 |
Effect of camostat mesilate for the treatment of advanced diabetic nephropathy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Drug Therapy, Combina | 1990 |